When COVID-19 swept across the globe in 2020, it exposed what supply chain professionals had long known but struggled to elevate as a strategic priority: American healthcare was dangerously dependent on a fragile, globally concentrated network for the supplies, devices, and pharmaceuticals that keep patients alive and that outdated healthcare supply chain technology was a critical part of the problem. N95 masks were backordered for months. PPE was being rationed. Generic drugs sourced primarily from India and China suddenly became geopolitical chess pieces.
In the years that followed, many health systems made meaningful strides — diversifying suppliers, investing in domestic sourcing, building buffer inventory. But “many” is doing a lot of work in that sentence. For every health system that used the pandemic as a forcing function for structural reform, others returned to business as usual once the immediate crisis subsided. And now, with a new wave of disruptions hitting multiple directions simultaneously, the consequences of that inaction are becoming painfully clear.
A Perfect Storm, Again
Today, healthcare supply chain leaders are contending with pressures that would be daunting individually. Together, they represent an unprecedented convergence of risk.
Tariffs are reshaping the cost structure of care. The sweeping tariff policies of the Trump administration have sent shock waves through the medical supply sector. Tariffs on medical devices currently range from 10% to 50% depending on country of origin, and the Section 232 investigation announced in late 2025 signals further increases may be coming. A Black Book Research survey found that 82% of healthcare professionals predicted hospital supply costs would rise by at least 15% within six months due to higher import expenses — and 94% of healthcare administrators said they would need to reduce procurement volumes or delay equipment upgrades as a result. Meanwhile, Vizient’s forecasts have been revised upward repeatedly, with the latest outlook projecting a 2.41% increase in non-pharmacy supply costs for 2026, alongside a 3.35% rise in pharmaceutical spending.
For hospitals already operating on razor-thin margins, this is not an abstraction. As one supply chain director put it plainly: “Our reimbursement hasn’t changed, so now the margins, which are razor thin as it is in healthcare, are going to be impacted again.”
The Middle East conflict is closing global shipping lanes. Geopolitical instability in the Middle East has triggered a cascade of logistics disruptions that extend far beyond the region itself. The closure of key shipping routes and renewed risks in the Red Sea have forced carriers to divert to longer, costlier alternatives. Air freight rates on Asia-to-Europe routes have risen dramatically as planes are rerouted around constrained airspace. This matters enormously for healthcare because the Middle East sits at the center of global air cargo networks — accounting for roughly 13% of world air freight — and pharmaceutical products manufactured in Asia typically move through Middle Eastern airports en route to markets worldwide. The impact has already materialized: aspirin shortages cascaded through supply chains in late 2025, with some wholesalers charging exponentially more than typical prices. Generic drug availability — historically the most price-sensitive and globally concentrated category — is particularly vulnerable.
COVID’s lessons remain unlearned at too many organizations. According to research from Argon & Co, only 22% of pharma firms were actively preparing for geopolitical disruption at the end of 2025. A supply chain manager at Main Line Health put it directly: “Although there have been improvements in some areas, it’s crucial for us to remain vigilant and proactive. The supply chain is still fractured in the aftermath of COVID-19.” The pandemic exposed the U.S. healthcare sector’s inability to meet demand for life-saving equipment during a crisis. The structural conditions that created that vulnerability — deep dependence on single-source foreign suppliers, inadequate real-time visibility, reactive rather than predictive management — have not been sufficiently addressed.
The Technology Gap at the Heart of the Problem
Here is the uncomfortable truth that sits beneath each of these disruptions: many health systems lack the technological infrastructure to see the problem coming, model its impact, or respond quickly enough to protect patient care.
Legacy enterprise resource planning (ERP) systems, siloed data environments, and manual procurement workflows were not built for the kind of dynamic, multi-variable risk management that today’s supply chain demands. When a geopolitical event in the Middle East can simultaneously affect the availability of active pharmaceutical ingredients, air freight costs, and rare-earth materials used in imaging equipment, a supply chain organization that relies on spreadsheets and reactive ordering is already behind.
The data exists. What too many organizations lack is the architecture to use it.
Predictive analytics platforms can forecast demand volatility and flag supplier risk before shortages materialize. AI-powered tools can optimize inventory positioning across systems in real time. Digital twins can simulate supply chain disruptions and model contingency responses before they’re needed. Agentic AI systems can automate procurement decisions and continuously learn from outcomes. Blockchain and real-time tracking technologies can provide the end-to-end visibility that remains elusive in many health systems.
But none of this is possible when legacy infrastructure creates data silos that prevent a coherent view of the supply chain. The digitization gap isn’t just a technology challenge — it’s a patient safety risk.
From Visibility to Resilience: What the Path Forward Looks Like
The healthcare organizations navigating today’s disruptions most effectively share a common characteristic: they invested in data and technology infrastructure before the crisis hit.
Cleveland Clinic, for example, has been deploying AI and automation to streamline supply chain workflows and improve accuracy across its operations — work that positions the system to respond more nimbly when external shocks arrive. Northwestern Medicine has focused on bridging the gap between supply chain processes and clinical workflows through advanced analytics, ensuring that data-driven tools produce both cost savings and quality improvements. Premier, Inc. is developing AI-enabled solutions designed to enhance transparency and efficiency across provider and supplier networks, helping health systems build the real-time intelligence they need to navigate volatility.
These are not theoretical futures. They are operational realities at organizations that made the decision to modernize.
For the health systems that haven’t yet made that investment, the calculus is shifting rapidly. As one supply chain leader observed, “Shifting an organization’s use of artificial intelligence from a buzzword to a competency will be the key to staying ahead of operational and financial pressures.” The question is no longer whether AI and predictive analytics belong in healthcare supply chain management. It’s how quickly organizations can close the gap between their current capabilities and what the environment now demands.
The Conversation Healthcare Leaders Need to Have
Against this backdrop, the Healthcare Supply Chain Technology Summit, taking place June 11–12, 2026, in Boston, arrives at a moment of genuine urgency.
Hosted at Northeastern University’s Executive Conference Center with panoramic views of Boston, the summit brings together supply chain leaders, health IT professionals, procurement executives, and industry innovators for a focused, practical exploration of the technologies reshaping the field. The agenda spans the full arc of what modern supply chain transformation requires: from the strategic framing of how to turn cost pressure into competitive advantage, to the technical specifics of how predictive analytics models actually work under the hood.
Key sessions include a fireside chat on moving from supply chain visibility to genuine resilience — a distinction that matters enormously when visibility alone doesn’t prevent shortages. A dedicated case study from Premier, Inc. offers a real-world playbook on integrating predictive analytics with legacy infrastructure, addressing the interoperability challenges, data quality concerns, and change management realities that derail so many digitization efforts. Cleveland Clinic’s project manager for Automation and AI will share firsthand insights on how the organization is harnessing these technologies to transform supply chain operations at scale.
Speakers also address the workforce dimension of this transformation — because technology alone doesn’t build a resilient supply chain. Healthcare organizations need professionals with skills in data science, risk management, and supplier relationship management, and the Summit’s panel on workforce development confronts the talent gaps that stand in the way of operational progress.
Cybersecurity gets its own dedicated session, reflecting a growing recognition that the connected supply chain is also an attack surface. With MassCyberCenter’s director leading a simulation-based exploration of cyber threats to healthcare logistics, attendees will leave with concrete frameworks for protecting supply chain operations from the digital vulnerabilities that increasingly accompany digital transformation.
Speakers represent some of the most respected voices in the field, including supply chain executives from Northwestern Medicine, Boston Children’s Hospital, and Cleveland Clinic, alongside the Chief Digital Officer of the Commonwealth of Massachusetts and the Editor-in-Chief of Healthcare Purchasing News.
The Stakes Are Too High for Incremental Thinking
The disruptions hitting healthcare supply chain technology today — tariffs, geopolitical conflict, persistent structural fragility — are not temporary inconveniences to be managed around. They are the new operating environment.
COVID offered a warning. The sector responded partially. Now the warning is being issued again, with the added complexity of an unstable global trade environment and supply routes that can shift overnight based on events thousands of miles away.
The organizations that come through this period strongest will not be those that waited for clarity before investing in technology. They will be those that built the predictive, data-driven, digitally integrated supply chains capable of absorbing shocks before those shocks become crises.
That work starts with the right conversations, with the right peers, in the right room.
The Healthcare Supply Chain Technology Summit is that room.
The Healthcare Supply Chain Technology Summit takes place June 11–12, 2026 at Northeastern University’s Executive Conference Center in Boston, MA. Early bird registration rates are available through April 17. Learn more and register at icdevents.com.
Sources: Becker’s Hospital Review, HFMA, AAMC, Healthcare Dive, ISM, Pharmaphorum, UNC Kenan-Flagler Business School Center for the Business of Health, NHS Supply Chain, European Medical Journal